BC Week In Review | Sep 1, 2017
Company News

CSL Behring acquires Calimmune

The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc. (Tucson, Ariz.), gaining two ex vivo autologous gene therapy candidates and two stem cell therapy technologies. Calimmune will...
BC Extra | Aug 28, 2017
Company News

CSL Behring acquires Calimmune

The CSL Behring subsidiary of CSL Ltd. (ASX:CSL) said it will acquire gene therapy company Calimmune Inc. (Tucson, Ariz.), gaining two ex vivo autologous gene therapy candidates and two stem cell therapy technologies. Calimmune will...
Items per page:
1 - 2 of 2